Literature DB >> 24985244

Outcome of laparoscopic Nissen fundoplication for gastroesophageal reflux disease in non-responders to proton pump inhibitors.

Emad Hamdy1, Ayman El Nakeeb, Hosam Hamed, Mohamed El Hemaly, Nabil Gad ElHak.   

Abstract

BACKGROUND: Gastroesophageal reflux disease (GERD) is a common public health problem. Medical treatment remains the first line of treatment of GERD. Failure of medical treatment may occur in up to 45% of GERD patients. This study aims to evaluate the outcome of laparoscopic Nissen fundoplication (LNF) as a means of antireflux surgery in patients with poor response to anti-reflux medication. PATIENTS AND METHODS: This is a prospective study of patients who underwent LNF in the period between January 2000 and December 2010 in the Gastrointestinal Surgical Center, Mansoura University, Egypt. Patients were assessed preoperatively and postoperatively, after 1 year, by clinical examination, esophagogastroscope, barium esophagography, esophageal manometry and 24-h pH monitoring. Patient satisfaction after surgery was also graded through a questionnaire.
RESULTS: The study population was 370 patients. 296 patients were good responders to proton pump inhibitors (PPI) while 74 patients were PPI non-responders. Preoperatively, atypical reflux symptoms were significantly more in PPI non-responders (P = 0.006). On follow-up, PPI responders significantly reported relief of heartburn (P = 0.01) and regurgitation (P = 0.04). Patient satisfaction was more in PPI responders (P = 0.04). Both groups were comparable regarding anatomical and functional assessment. Integrity of the wrap was higher in PPI responders (P = 0.04).
CONCLUSION: PPI non-responders should not be precluded from LNF. Thorough assessment is mandatory to confirm GERD diagnosis. A substantial proportion of PPI failures show good response to LNF but significantly than clinical response in PPI responders. Increased likelihood of poor outcome after surgery should be discussed with the patient.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24985244     DOI: 10.1007/s11605-014-2584-3

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  26 in total

1.  Multivariate analysis of factors predicting outcome after laparoscopic Nissen fundoplication.

Authors:  G M Campos; J H Peters; T R DeMeester; S Oberg; P F Crookes; S Tan; S R DeMeester; J A Hagen; C G Bremner
Journal:  J Gastrointest Surg       Date:  1999 May-Jun       Impact factor: 3.452

2.  Preoperative factors predicting clinical outcome following laparoscopic fundoplication.

Authors:  Annina Staehelin; Urs Zingg; Peter G Devitt; Adrian J Esterman; Lorelle Smith; Glyn G Jamieson; David I Watson
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

3.  Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.

Authors:  R Carlsson; J Dent; R Watts; S Riley; R Sheikh; J Hatlebakk; K Haug; G de Groot; A van Oudvorst; A Dalväg; O Junghard; I Wiklund
Journal:  Eur J Gastroenterol Hepatol       Date:  1998-02       Impact factor: 2.566

Review 4.  American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease.

Authors:  Peter J Kahrilas; Nicholas J Shaheen; Michael F Vaezi
Journal:  Gastroenterology       Date:  2008-09-16       Impact factor: 22.682

Review 5.  Medical treatments for the maintenance therapy of reflux oesophagitis and endoscopic negative reflux disease.

Authors:  C Donnellan; N Sharma; C Preston; P Moayyedi
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

Review 6.  Systematic review: the association between symptomatic response to proton pump inhibitors and health-related quality of life in patients with gastro-oesophageal reflux disease.

Authors:  A Becher; H El-Serag
Journal:  Aliment Pharmacol Ther       Date:  2011-07-20       Impact factor: 8.171

7.  Symptom-focused results after laparoscopic fundoplication for refractory gastroesophageal reflux disease--a prospective study.

Authors:  Stavros A Antoniou; Panagiotis Delivorias; George A Antoniou; Ioannis Natsiopoulos; Athanasios Kalambakas; Jan Dalenbäck; Charalambos Makridis
Journal:  Langenbecks Arch Surg       Date:  2008-02-20       Impact factor: 3.445

8.  Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.

Authors:  Anita Gasiorowska; Tomas Navarro-Rodriguez; Christopher Wendel; Elizabeth Krupinski; Zvi H Perry; Kristina Koenig; Bridget Moty; Jeannette Powers; Ronnie Fass
Journal:  Am J Gastroenterol       Date:  2009-06-02       Impact factor: 10.864

9.  Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice Parameters Committee of the American College of Gastroenterology.

Authors:  K R DeVault; D O Castell
Journal:  Arch Intern Med       Date:  1995-11-13

10.  Comparison of clinical characteristics of patients with gastroesophageal reflux disease who failed proton pump inhibitor therapy versus those who fully responded.

Authors:  Ram Dickman; Mona Boaz; Shoshanna Aizic; Zaza Beniashvili; Ronnie Fass; Yaron Niv
Journal:  J Neurogastroenterol Motil       Date:  2011-10-31       Impact factor: 4.924

View more
  10 in total

Review 1.  Management of refractory typical GERD symptoms.

Authors:  Emidio Scarpellini; Daphne Ang; Ans Pauwels; Adriano De Santis; Tim Vanuytsel; Jan Tack
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-04-14       Impact factor: 46.802

2.  Mind the Gap: Current Treatment Alternatives for GERD Patients Failing Medical Treatment and Not Ready for a Fundoplication.

Authors:  Phuong Huynh; Vani Konda; Suchakree Sanguansataya; Marc A Ward; Steven G Leeds
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2020-12-16       Impact factor: 1.719

3.  Reflux and Voice Disorders: Have We Established Causality?

Authors:  G Todd Schneider; Michael F Vaezi; David O Francis
Journal:  Curr Otorhinolaryngol Rep       Date:  2016-07-09

Review 4.  ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease.

Authors:  Philip O Katz; Kerry B Dunbar; Felice H Schnoll-Sussman; Katarina B Greer; Rena Yadlapati; Stuart Jon Spechler
Journal:  Am J Gastroenterol       Date:  2022-01-01       Impact factor: 10.864

Review 5.  Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease.

Authors:  L Hillman; R Yadlapati; M Whitsett; A J Thuluvath; M A Berendsen; J E Pandolfino
Journal:  Dis Esophagus       Date:  2017-09-01       Impact factor: 3.429

6.  Factors predicting outcomes of laparoscopic Nissen fundoplication for gastroesophageal reflux disease: experience at a single institution in Korea.

Authors:  Joong-Min Park; Beom Jin Kim; Jae Gyu Kim; Kyong-Choun Chi
Journal:  Ann Surg Treat Res       Date:  2017-03-24       Impact factor: 1.859

7.  Persistent dysphagia is a rare problem after laparoscopic Nissen fundoplication.

Authors:  Milena Nikolic; Katrin Schwameis; Georg Semmler; Reza Asari; Lorenz Semmler; Ariane Steindl; Berta O Mosleh; Sebastian F Schoppmann
Journal:  Surg Endosc       Date:  2018-08-31       Impact factor: 4.584

Review 8.  Preoperative physiological esophageal assessment for anti-reflux surgery: A guide for surgeons on high-resolution manometry and pH testing.

Authors:  Michael Yodice; Alexandra Mignucci; Virali Shah; Christopher Ashley; Micheal Tadros
Journal:  World J Gastroenterol       Date:  2021-04-28       Impact factor: 5.742

Review 9.  Pre-operative clinical and instrumental factors as antireflux surgery outcome predictors.

Authors:  Salvatore Tolone; Giorgia Gualtieri; Edoardo Savarino; Marzio Frazzoni; Nicola de Bortoli; Manuele Furnari; Giuseppina Casalino; Simona Parisi; Vincenzo Savarino; Ludovico Docimo
Journal:  World J Gastrointest Surg       Date:  2016-11-27

Review 10.  Proton pump inhibitor-refractory gastroesophageal reflux disease: challenges and solutions.

Authors:  Joseph Mermelstein; Alanna Chait Mermelstein; Maxwell M Chait
Journal:  Clin Exp Gastroenterol       Date:  2018-03-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.